Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote & News

Company Profile

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcino...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 794 9600

Fax: 858 794 9605

Website: www.calidibio.com

Address:

4475 Executive Drive, Suite 200, San Diego, United States

race2zero Mar. 14 at 4:20 PM

$CLDI more in response

1 · Reply

race2zero Mar. 14 at 3:01 AM

$CLDI type this into ChatGPT for a lesson of what you are seeing here: Explain to me the anatomy of a bio tech penny stock scam

0 · Reply

race2zero Mar. 13 at 10:31 PM

$CLDI @E8000 shocker that @Dailyfollower didn’t answer your question, but just posted more incoherent nonsense

0 · Reply

race2zero Mar. 13 at 7:36 PM

$CLDI come on! Give me the .20s today

0 · Reply

race2zero Mar. 13 at 7:32 PM

$CLDI another new all time low

0 · Reply

Dailyfollower Mar. 13 at 6:43 PM

$CLDI This is an opportunity for those with a high average purchase price at these levels.👆👆👆💥💥💥😉✍️

0 · Reply

Dailyfollower Mar. 13 at 6:35 PM

$CLDI It will recover to 0.36 first.💥💥💥

0 · Reply

Dailyfollower Mar. 13 at 6:30 PM

$CLDI ✍️

0 · Reply

Dailyfollower Mar. 13 at 6:08 PM

$CLDI ✍️

0 · Reply

race2zero Mar. 13 at 6:02 PM

$CLDI @E8000 so he posted here again today but didn’t answer your question…I’m not surprised 🤣 repost this so he sees me calling him out since he blocked me

0 · Reply

Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing

Mar 9, 2026, 8:50 PM EDT - 6 days ago

Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Mar 6, 2026, 8:30 AM EST - 9 days ago

Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering

Mar 5, 2026, 5:57 PM EST - 10 days ago

Calidi Biotherapeutics Announces Proposed Public Offering

Feb 20, 2026, 8:00 AM EST - 23 days ago

Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference

Feb 12, 2026, 8:00 AM EST - 4 weeks ago

Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference

Nov 17, 2025, 8:00 AM EST - 4 months ago

Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025

Nov 13, 2025, 4:15 PM EST - 4 months ago

Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights

Aug 21, 2025, 6:33 PM EDT - 7 months ago

Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option

Aug 20, 2025, 9:15 AM EDT - 7 months ago

Calidi Biotherapeutics Announces Pricing of $6 Million Underwritten Public Offering

Aug 8, 2025, 4:15 PM EDT - 7 months ago

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

Jul 25, 2025, 4:45 PM EDT - 8 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 8 months ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on July 24

Jul 10, 2025, 8:30 AM EDT - 8 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Platform Designed to Transform Landscape of Cancer Treatment

Jul 9, 2025, 2:01 PM EDT - 8 months ago

Calidi Biotherapeutics Announces Exercise of Warrants for $4.6 Million of Gross Proceeds

Jul 8, 2025, 8:30 AM EDT - 8 months ago

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Jun 27, 2025, 8:00 AM EDT - 9 months ago

Calidi Biotherapeutics Announces Shareholder Letter from CEO

Apr 25, 2025, 8:00 AM EDT - 11 months ago

Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711

Apr 16, 2025, 9:30 AM EDT - 11 months ago

Global X Offers Precise U.S. Equity Exposure with Launch of Domestic Focused Funds

EGLE

Mar 31, 2025, 4:30 PM EDT - 1 year ago

Calidi Biotherapeutics Announces Closing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 28, 2025, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $3.9 Million Registered Direct Offering and Concurrent Private Placement

Mar 10, 2025, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Demonstrated Ability To Deliver Transient Gene Therapy (Payload) To Tumors Using Systemic Platform

Feb 28, 2025, 9:00 AM EST - 1 year ago

Calidi Biotherapeutics and OS Therapies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

OSTX

Feb 24, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital

Jan 29, 2025, 8:00 AM EST - 1 year ago

Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on February 5

Jan 28, 2025, 8:00 AM EST - 1 year ago

Calidi Biotherapeutics Announces Bolstered Cash Balance and Termination of its Standby Equity Purchase Agreement

Jan 10, 2025, 4:30 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $4.25 Million Public Offering of Common Stock

Jan 10, 2025, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $4.25 Million Public Offering of Common Stock

Nov 15, 2024, 4:05 PM EST - 1 year ago

Calidi Biotherapeutics Announces Closing of $7.5 Million Public Offering of Common Stock

Nov 14, 2024, 8:30 AM EST - 1 year ago

Calidi Biotherapeutics Announces Pricing of $7.5 Million Public Offering of Common Stock

Nov 12, 2024, 5:29 PM EST - 1 year ago

Calidi Biotherapeutics Reports Third Quarter 2024 Operating and Financial Results

Oct 25, 2024, 9:00 AM EDT - 1 year ago

Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

NXL

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Calidi Biotherapeutics to Present Data Supporting RTNova at Upcoming Scientific Conferences

Oct 23, 2024, 8:31 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement

Oct 18, 2024, 11:00 PM EDT - 1 year ago

NYSE American to Commence Delisting Proceedings with Respect to the Warrants of Calidi Biotherapeutics, Inc. (CLDI WS)

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Calidi Biotherapeutics and Gorilla Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

GRRR

Aug 13, 2024, 5:37 PM EDT - 1 year ago

Calidi Biotherapeutics Reports Second Quarter 2024 Operating and Financial Results

Aug 2, 2024, 9:00 AM EDT - 1 year ago

GreenPower Motor and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Jul 29, 2024, 9:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Launch of Nova Cell Subsidiary and $3 Million Aggregate Investment from Dr. Ronald Rigor

Jul 18, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform

Jul 16, 2024, 8:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Dr. Mark Gilbert to Medical Advisory Board

Jul 5, 2024, 4:15 PM EDT - 1 year ago

Calidi to Effect Reverse Stock Split

Jun 27, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Appointment of Cancer Immunotherapy Pioneer Dr. George Peoples to Board of Directors

Jun 11, 2024, 4:05 PM EDT - 1 year ago

Calidi Biotherapeutics to Host Exclusive Live Investor Webinar and Q&A Session on June 13

Jun 10, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Collaborates with SIGA Technologies to Advance Calidi's Revolutionary RTNova Virotherapy for Lung Cancer and Metastatic Solid Tumors

Jun 3, 2024, 7:00 AM EDT - 1 year ago

Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting

May 31, 2024, 8:51 AM EDT - 1 year ago

Calidi Biotherapeutics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

race2zero Mar. 14 at 4:20 PM

$CLDI more in response

1 · Reply

race2zero Mar. 14 at 3:01 AM

$CLDI type this into ChatGPT for a lesson of what you are seeing here: Explain to me the anatomy of a bio tech penny stock scam

0 · Reply

race2zero Mar. 13 at 10:31 PM

$CLDI @E8000 shocker that @Dailyfollower didn’t answer your question, but just posted more incoherent nonsense

0 · Reply

race2zero Mar. 13 at 7:36 PM

$CLDI come on! Give me the .20s today

0 · Reply

race2zero Mar. 13 at 7:32 PM

$CLDI another new all time low

0 · Reply

Dailyfollower Mar. 13 at 6:43 PM

$CLDI This is an opportunity for those with a high average purchase price at these levels.👆👆👆💥💥💥😉✍️

0 · Reply

Dailyfollower Mar. 13 at 6:35 PM

$CLDI It will recover to 0.36 first.💥💥💥

0 · Reply

Dailyfollower Mar. 13 at 6:30 PM

$CLDI ✍️

0 · Reply

Dailyfollower Mar. 13 at 6:08 PM

$CLDI ✍️

0 · Reply

race2zero Mar. 13 at 6:02 PM

$CLDI @E8000 so he posted here again today but didn’t answer your question…I’m not surprised 🤣 repost this so he sees me calling him out since he blocked me

0 · Reply

race2zero Mar. 13 at 5:37 PM

$CLDI records are made to be broken! This breaks it’s all time low everyday!

0 · Reply

Dailyfollower Mar. 13 at 4:39 PM

$CLDI ✍️

0 · Reply

race2zero Mar. 13 at 1:49 PM

$CLDI every single day you’ll see 3 blocks on the bid and 3 on the ask exactly the same. Might be 1700, 1900 or whatever, but workout daily they are always there. You have no chance with this…track it and you’ll see

0 · Reply

race2zero Mar. 13 at 1:17 PM

$CLDI shocker, another red start to the day 😂😂 we might get some reverse split news today

0 · Reply

race2zero Mar. 12 at 11:07 PM

$CLDI @E8000 he isn’t going to answer you because it doesn’t mean anything

0 · Reply

race2zero Mar. 12 at 7:43 PM

$CLDI and boom! Another all-time low 🤣🤣

0 · Reply

Dailyfollower Mar. 12 at 6:40 PM

$CLDI Chart so tight👌👆👆👆😉💥

0 · Reply

Dailyfollower Mar. 12 at 6:22 PM

$CLDI Everyone's costs are known and are also collected by international intermediary institutions.😉👆👆👆💥

1 · Reply

race2zero Mar. 12 at 6:16 PM

$CLDI what is that I see? Is it? Yes, yes it is!!! Another all time low! If you bought this at the beginning, you only need it to go to $1,173.27 to be even🤣🤣🤣for those counting at home that means it’s down 99.97% all time. Once the next reverse split comes this will be down 99.99% and they’ll stop counting

0 · Reply

Dailyfollower Mar. 12 at 6:15 PM

$CLDI The levels are full; don't neglect the small additions to realize the power here.😎👆👆👆🤝💥💥💥✍️

0 · Reply

race2zero Mar. 12 at 6:03 PM

$CLDI @Dailyfollower got a love a guy that talks smack and then blocks me. Someone remind him that just because he doesn’t read the truth doesn’t mean it isn’t the truth🤣🤣🤣🤣🤦🏻‍♂️🤦🏻‍♂️🤦🏻‍♂️😂😂

0 · Reply

Dailyfollower Mar. 12 at 6:02 PM

$CLDI 👆👆👆💥💥💥✍️

0 · Reply

Market Cap	2.34M
Revenue (ttm)	0.00
Net Income (ttm)	-22.14M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.08

Volume	216,300
Avg Vol	205,110
Day's Range	N/A - N/A
Shares Out	7.37M
Stochastic %K	1%
Beta	1.11
Analysts	Sell
Price Target	$10.00